Statement of Changes in Beneficial Ownership (4)
12 September 2020 - 7:11AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Greene Barry E |
2. Issuer Name and Ticker or Trading Symbol
ALNYLAM PHARMACEUTICALS, INC.
[
ALNY
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President |
(Last)
(First)
(Middle)
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/9/2020 |
(Street)
CAMBRIDGE, MA 02142
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 7/16/2020 | | G(1) |
V
| 3176 | A | $0.0 | 65412 | D | |
Common Stock | 9/9/2020 | | M(2) | | 44530 | A | $9.14 | 114873 | D | |
Common Stock | 9/9/2020 | | S(2) | | 14075 | D | $122.66 (3) | 100798 | D | |
Common Stock | 9/9/2020 | | S(2) | | 27109 | D | $123.39 (4) | 73689 | D | |
Common Stock | 9/9/2020 | | S(2) | | 3346 | D | $124.38 (5) | 70343 | D | |
Common Stock | 7/16/2020 | | G(1) |
V
| 155 | A | $0.0 | 155 | I | by Dependent |
Common Stock | 7/16/2020 | | G(1) |
V
| 155 | D | $0.0 | 3331 | I | by Trust |
Common Stock | 7/16/2020 | | G(1) |
V
| 155 | D | $0.0 | 3176 | I | by Trust |
Common Stock | 7/16/2020 | | G(1) |
V
| 3176 | D | $0.0 | 0 | I | by Trust |
Common Stock | | | | | | | | 3003 | I | by Managed Account (6) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (right to buy) | $9.14 | 9/9/2020 | | M (2) | | | 44530 | (7) | 12/8/2020 | Common Stock | 44530 | $0.0 | 0 | D | |
Explanation of Responses: |
(1) | Represents shares of ALNY common stock distributed upon termination of the Barry E. Greene Qualified Annuity Interest Trust (GRAT), of which the reporting person is the sole Trustee. Upon termination of the trust on July 16, 2020, 155 of the shares held by the GRAT were gifted to a non-dependent child, and 155 of the shares were transferred to the reporting persons dependent child. The remaining 3,176 shares were distributed to the reporting person. |
(2) | All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2020. The 44,530 options exercised and sold by the reporting person were due to expire on December 8, 2020. |
(3) | Sale prices ranged from $122.00 to $123.00. |
(4) | Sale prices ranged from $123.01 to $124.00. |
(5) | Sale prices ranged from $124.03 to $124.87. |
(6) | Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. |
(7) | The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Greene Barry E 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE, MA 02142 |
|
| President |
|
Signatures
|
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Barry E. Greene | | 9/11/2020 |
**Signature of Reporting Person | Date |
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Apr 2024 to May 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From May 2023 to May 2024